Welcome

This website is intended for international healthcare professionals with an interest in the treatment of Nocturia. By clicking the link below you are declaring and confirming that you are a healthcare professional. Please answer a few short questions about this resource centre.

You are here

NICE Clinical Guidelines 2010: The management of lower urinary tract symptoms in menNICE National Institute for Health and Clinical Excellence

NICE National Institute for Health and Clinical Excellence

All NICE Guidelines are designed and funded to support the NHS in the UK and have no formal jurisdiction outside of this territory

Editor's comments:
This is a very important and exhaustive Guideline which reviews a number of important aspects of the management of male LUTS, as: diagnostic tests available for evaluation and identification of underlying pathophysiology; the role of the conservative and lifestyle measures; pharmacotherapy, considering pharmacological agents as monotherapy or in combination; minimally invasive procedures and other surgical options. The Guidelines covers men (18 and over) with a clinical working diagnosis of LUTS but does not cover women. One of the most important aspects of this Guideline is that conservative, pharmacological, surgical, and complementary or alternative treatments are considered in terms of clinical and cost effectiveness. Indeed, the economic profile has been used to present cost and cost-effectiveness estimates from published studies or analyses conducted for the Guidelines. The NICE Guidelines also produced recommendations for each individual diagnostic measure and treatment modality for LUTS in men. With regards to Nocturia, the most important message is the consideration of the reduced frequency of night time voiding due to nocturnal polyuria as the most important outcome, which could have significant impact on patient’s sleep quality and quality of life. In addition, the NICE Guidelines “consider to offer oral desmopressin to men with nocturnal polyuria if other medical causes have been exhausted and they have not benefited from other treatments”.

Ferring Pharmaceuticals LogoMade possible by an
educational grant
from Ferring

World Sleep Day

Search

E-Alert

Subscribe to our E-Alert to stay informed of all new content.

Lecture from the ICS

6th - 9th October 2015

ICS 2015: Nocturia Plenary Satellite Symposium, Montreal, Canada

Program Chair: Philip E. V. Kerrebroeck

Featured Editorial

Defining Nocturnal Polyuria
By Prof. Philip van Kerrebroeck

Best read article

  • Nocturia in older men

    Boris van Doorn, J.L.H. Ruud Bosch

    Maturitas, Volume 71, Issue 1, 2012, pages 8 - 12

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.
The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.

Book on Nocturia!

Nocturia: Causes, Consequences and Clinical Approaches Is the first volume exclusively on the topic of nocturia and is designed to be a comprehensive treatise on the subject.